General Information of the Compound
Compound ID
CP0433505
Compound Name
(5Z)-5-[(3-bromo-4-hydroxyphenyl)methylidene]-3-[4-(piperazine-1-carbonyl)phenyl]-1,3-oxazolidine-2,4-dione
    Show/Hide
Structure
Formula
C21H18BrN3O5
Molecular Weight
472.295
Canonical SMILES
Oc1ccc(\C=C2/OC(=O)N(C2=O)c2ccc(cc2)C(=O)N2CCNCC2)cc1Br
    Show/Hide
InChI
InChI=1S/C21H18BrN3O5/c22-16-11-13(1-6-17(16)26)12-18-20(28)25(21(29)30-18)15-4-2-14(3-5-15)19(27)24-9-7-23-8-10-24/h1-6,11-12,23,26H,7-10H2/b18-12-
    Show/Hide
InChIKey
FWGWAYOSOGVCHH-PDGQHHTCSA-N
Physicochemical Property
logP
2.7244
Rotatable Bonds
3
Heavy Atom Count
30
Polar Areas
99.18
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
6
Complexity
30

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 70687582
ChEMBL ID
CHEMBL2018228
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03321, 17-beta-hydroxysteroid dehydrogenase type 3
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  1
1
IC50 = 42 nM
   TI
   LI
   LO
   TS